Skip to content

Maryland · Nonprofit

INSTITUTE FOR IN VITRO SCIENCES INC

INSTITUTE FOR IN VITRO SCIENCES INC (Maryland) receives grants from 5 organizations whose IRS filings report $433,270 to it, the largest being L BRANDS FOUNDATION ($240,000). 5 of them have funded it in more than one year.

Revenue FY2025
$7.9M
Funders on record
5
Grants received
$433k
Net assets
$2.4M
5/5 repeat funderspeak grant-dependency 4%
01What it does

What Institute for in Vitro Sciences Inc does

Mission

The mission of the institute for in vitro sciences (iivs) is to drive the optimization and application of scientifically robust in vitro methods that are accepted by regulatory agencies and adopted by industry worldwide. To create a forum in which industry, regulatory agencies and animal welfare organizations can work together to develop humane scientific tools for testing. To utilize our expertise to create educational and outreach programs that will expand the adoption of non-animal test methods around the globe.

As stated on its FY2025 Form 990.

Programs

  1. Research and testing: iivs worked with more than sixty companies to determine the appropriate non-animal testing strategies, conduct testing, and assist in interpretation of data. Over 880 compounds/products were tested at the iivs laboratory - mostly in more than one test. Iivs continues to optimize and standardize in vitro methods to make them suitable for industry and regulatory needs. Many of these efforts are in collaboration with stakeholders such as industry, government and ngos. Advancements are shared with the scientific community through presentations and publications so that other industries and regulatory scientists can benefit. Iivs has developed and promoted the use of human precision cut lung slices (hpcls) for potential regulatory application as an alternative to using animals for inhalation and respiratory endpoints. Based upon our successful use of hpcls in in-house studies, stakeholders have inquired whether they could procure these hpcls tissues for use within their own laboratories. Iivs prepared and qualified hpcls tissues for 30 sponsor-run laboratory studies that would have otherwise used animals.

    $6,332,999 spent$6,805,283 earned by the program
    86% of program spending
  2. Education and outreach: iivs participates in numerous training activities for a variety of stakeholders including industry and regulatory scientists. These trainings are tailored for the specific audience and generally include lectures, hands-on demonstrations and data interpretation. Two major programs in which iivs participates are the physicians committee for responsible medicine nura training and the animal free safety assessment collaboration coordinated by humane society international. Iivs scientists were invited to participate in expert panels convened by the organization for economic cooperation and development (oecd) which harmonizes in vitro testing approaches for the worldwide scientific community. These panels discussed new methods for genetic toxicology, skin sensitization, eye irritation and skin corrosion. Iivs is leading efforts with industry consortia and 2 divisions of the u.s. Federal drug administration to apply non-animal methods for specific endpoints. Iivs is also involved in efforts to support the u.s. Environmental protection agency's goal to reduce reliance on animal models. Iivs staff hold board positions within societies that have the mission to work…

    $1,066,858 spent$263,773 earned by the program
    14% of program spending

The 2 programs described on its FY2025 Form 990, listed largest first by expense. Program spending in total: $7,399,857.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($4.5M) Expenses 100 ($4.5M) Net assets 100 ($1.6M)2018 Revenue 123 ($5.5M) Expenses 115 ($5.2M) Net assets 118 ($1.9M)2019 Revenue 124 ($5.5M) Expenses 130 ($5.9M) Net assets 129 ($2.1M)2020 Revenue 132 ($5.9M) Expenses 126 ($5.7M) Net assets 140 ($2.3M)2021 Revenue 146 ($6.5M) Expenses 134 ($6.1M) Net assets 167 ($2.7M)2022 Revenue 154 ($6.9M) Expenses 153 ($6.9M) Net assets 163 ($2.6M)2023 Revenue 155 ($6.9M) Expenses 158 ($7.2M) Net assets 145 ($2.3M)2024 Revenue 179 ($8.0M) Expenses 175 ($7.9M) Net assets 146 ($2.4M)2025 Revenue 178 ($7.9M) Expenses 174 ($7.9M) Net assets 147 ($2.4M)
'17'18'19'20'21'22'23'24'25
Revenue (178)Expenses (174)Net assets (147)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2021 to 2022, from $4.1M to $6.6M (+60%).

$2.7M
$3.0M
$3.5M
$4.3M
$4.1M
$6.6M
$6.2M
$5.9M
$5.6M
'17'18'19'20'21'22'23'24'25
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
2025
ContributionsProgram revenueInvestmentOther

Government-grant reliance: 2017 0% · 2020 1% · 2021 9% · 2022 1% · 2023 0% · 2024 1% · 2025 0%. Grants only. Government contracts and fees sit inside program revenue.

10% of INSTITUTE FOR IN VITRO SCIENCES INC’s revenue is contributions — about as donation-reliant as the typical peer (48% for the typical peer).

This organization
Typical peer · 12,352 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 4 of the last 9 reported years ran a deficit.

−$75k
’17
$293k
’18
−$378k
’19
$181k
’20
$433k
’21
−$62k
’22
−$288k
’23
$17k
’24
$18k
’25
1.0
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Chief executive

Rodger D Curren

CEO/board chair/secretary

As listed on its FY2025 Form 990.

'17'18'19'20'21'22'23'24'25
Listed101110121213141313
Joined·+1+0+2+1+2+1+2+0
No longer listed·01011030
03Who funds it

Who funds it, year by year

2017 → 2023: the base held at 3 funders, grant income fell $165k → $23k.

Funder
'17
'18
'19
'20
'21
'22
'23
'25*
total
$240k
funders
3
1
1
4
2
2
3
1

2 of 5 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 5% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of INSTITUTE FOR IN VITRO SCIENCES INC’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

INSTITUTE FOR IN VITRO SCIENCES INC leans on a few funders — its largest provides 55% of grant income and the top three 95%; half comes from just 1 funder.

the vertical line marks half of all grant income — 1 funder to its left

100% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund INSTITUTE FOR IN VITRO SCIENCES INC.

55%
largest funder
95%
top three
~3
effective funders

Largest funder’s share by year: 2017 61% · 2018 100% · 2019 100% · 2020 80% · 2021 99% · 2022 99% · 2023 56% — diversifying over time.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

Where its funders are

INSTITUTE FOR IN VITRO SCIENCES INC draws 100% of its grant income from funders outside Maryland, across 3 states in all.

OH
PA
VA

In-state vs out-of-state, by year

’17
’18
’19
’20
’22
’23
Maryland out of state home

Funder states come from each funder’s own filing. $20k arriving through sponsors registered in 2 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

INSTITUTE FOR IN VITRO SCIENCES INC's revenue grew 78% between 2017 and 2025.

Operating margin0% · below the median
Months of reserve1.0mo · bottom quartile
Revenue growth (annualized)7% · below the median

this organization peer median middle 50% of peers· 9,398 education nonprofits $1M–$10M, FY2025

Government funding INSTITUTE FOR IN VITRO SCIENCES INC receives

Grants and contracts to this organization from federal (USASpending) and state checkbooks, reconciled to its EIN. $200k on record.

Federal$200k
grants $200kcontracts $0
19
21
23
24
Top agencies
  • Department of Health and Human Services$200k

Federal grants vs contracts are distinguished; state line items keep their reported category. Matched by name + geography (the BMF), so coverage is partial and precision-first.

Organizations like INSTITUTE FOR IN VITRO SCIENCES INC

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Maryland

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

94% of spending goes to programs.

Program 94%Management 6%Fundraising 0%

Governance

8
board members
63%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention✓Board reviewed the 990✓Audited financials

Public support

59%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 10 states

WI
NY
OR
OH
PA
NJ
CA
VA
MD
TN

Screen this organization

A dated, signed PDF of the compliance screen for INSTITUTE FOR IN VITRO SCIENCES INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds INSTITUTE FOR IN VITRO SCIENCES INC?
INSTITUTE FOR IN VITRO SCIENCES INC (Maryland) receives grants from 5 organizations whose IRS filings report $433,270 to it, the largest being L BRANDS FOUNDATION ($240,000). 5 of them have funded it in more than one year.
How many funders does INSTITUTE FOR IN VITRO SCIENCES INC have?
IRS filings report 5 organizations giving $433,270 in grants to INSTITUTE FOR IN VITRO SCIENCES INC, 5 of which have funded it in more than one year.
Who is the largest funder of INSTITUTE FOR IN VITRO SCIENCES INC?
L BRANDS FOUNDATION is the largest funder on record, with $240,000 in grants. The full list of funders is on this page.
How can an organization like INSTITUTE FOR IN VITRO SCIENCES INC find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Maryland. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

Play a game about who funds Institute for in Vitro Sciences →

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 5 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing